{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:58:11Z","timestamp":1764079091185},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.lungcan.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T20:50:01Z","timestamp":1435179001000},"page":"268-273","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations"],"prefix":"10.1016","volume":"89","author":[{"given":"Lei","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2015.06.001_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-013-1199-y","article-title":"Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung","volume":"115","author":"Lee","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0130","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cncr.22565","article-title":"Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain","volume":"109","author":"Chen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cllc.2013.12.009","article-title":"Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era","volume":"15","author":"Riess","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0140","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archneur.1997.00550230037013","article-title":"Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases","volume":"54","author":"Chamberlain","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jjco\/hyg118","article-title":"Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone","volume":"33","author":"Kim","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0150","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.11449","article-title":"Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis","volume":"97","author":"Cole","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00280-006-0285-7","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates","volume":"59","author":"Stapleton","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s002800000253","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates","volume":"47","author":"Kerr","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.2011.40.1174","article-title":"Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer","volume":"31","author":"Welsh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0175","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/JTO.0b013e318294c8e8","article-title":"Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer","volume":"8","author":"Lee","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0180","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/neuonc\/nor121","article-title":"Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer","volume":"13","author":"Grommes","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0185","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.15_suppl.8110","article-title":"Phase I trial of icotinib combined with whole brain radiotherapy for EGFR-mutated non-small cell lung cancer patients with brain metastases","volume":"32","author":"Zhou","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clineuro.2012.03.048","article-title":"Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features","volume":"115","author":"Palma","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cncr.24041","article-title":"Neuro-oncology unit of the institute of biomedical investigation of B. Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features","volume":"115","author":"Bruna","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0200","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.4103\/2152-7806.111304","article-title":"Carcinomatous meningitis: leptomeningeal metastases in solid tumors","volume":"4","author":"Le Rhun","year":"2013","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2011.11.022","article-title":"Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era","volume":"76","author":"Park","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0210","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/annonc\/mdu261","article-title":"Erlotinib treatment of meningeal carcinomatosis in lung cancer: more is better","volume":"25","author":"Cessot","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-010-0128-6","article-title":"High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer","volume":"99","author":"Clarke","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/JTO.0b013e3182773f21","article-title":"Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors","volume":"8","author":"Lee","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0225","doi-asserted-by":"crossref","first-page":"e107161","DOI":"10.1371\/journal.pone.0107161","article-title":"Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis","volume":"9","author":"Zhang","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0230","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0235","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0929-6646(08)60201-6","article-title":"Cytologically proven meningeal carcinomatosis in patients with lung cancer: clinical observation of 34 cases","volume":"107","author":"Chuang","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.lungcan.2015.06.001_bib0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/JTO.0b013e3182398e4f","article-title":"Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy","volume":"7","author":"Morris","year":"2012","journal-title":"J Thorac Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021500286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021500286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T17:41:14Z","timestamp":1566927674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950021500286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S016950021500286X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.06.001","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}